CDKN3 promotes tumor progression and confers cisplatin...

Cancer Management and Research 2019 / 04 Vol. Volume 11

CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer

Wang, Jiansong, Che, Wencheng, Wang, Weimin, Su, Gongzhang, Zhen, Tianchang, Jiang, Zhongmin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 11
Journal:
Cancer Management and Research
DOI:
10.2147/CMAR.S193793
Date:
April, 2019
File:
PDF, 863 KB
2019
Conversion to is in progress
Conversion to is failed